For instance, in non-small cell lung cancer (NSCLC), upregulation A3B correlates positively with immunotherapy response biomarkers, including PD-L1 expression and T-cell infiltration (Wang et al., 2018). Here, CD274 is linked to non-small cell lung carcinoma.